Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)

NCT00002031 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Dinitrochlorobenzene

Sponsor

University of California, San Francisco